Sanofi may appeal French competition body fine

PARIS Tue May 14, 2013 4:17am EDT

Related Topics

PARIS May 14 (Reuters) - French drugmaker Sanofi said on Tuesday it objected to a fine by the French Competition Authority in a dispute over generic competition to its blood thinner, Plavix, and said it was considering a possible appeal.

The Competition Authority said it fined Sanofi 40.6 million euros ($52.7 million) over what it called a smear campaign aimed at stifling generic competition to Plavix. ($1 = 0.7703 euros) (Reporting by Dominique Vidalon; Editing by James Regan)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.